Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI107047

Effect of prostaglandin E1 on certain renal actions of parathyroid hormone

Nama P. Beck, Frederick R. DeRubertis, Michael F. Michelis, Robert D. Fusco, James B. Field, and Bernard B. Davis

1Veterans Administration Hospital, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15240

Find articles by Beck, N. in: PubMed | Google Scholar

1Veterans Administration Hospital, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15240

Find articles by DeRubertis, F. in: PubMed | Google Scholar

1Veterans Administration Hospital, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15240

Find articles by Michelis, M. in: PubMed | Google Scholar

1Veterans Administration Hospital, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15240

Find articles by Fusco, R. in: PubMed | Google Scholar

1Veterans Administration Hospital, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15240

Find articles by Field, J. in: PubMed | Google Scholar

1Veterans Administration Hospital, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15240

Find articles by Davis, B. in: PubMed | Google Scholar

Published September 1, 1972 - More info

Published in Volume 51, Issue 9 on September 1, 1972
J Clin Invest. 1972;51(9):2352–2358. https://doi.org/10.1172/JCI107047.
© 1972 The American Society for Clinical Investigation
Published September 1, 1972 - Version history
View PDF
Abstract

Parathyroid hormone increased basal adenyl cyclase activity and that increase was inhibited by prostaglandin E1 (PGE1). Tissue cyclic 3′,5′-adenosine monophosphate (cyclic AMP) concentrations were increased by parathyroid hormone and that increase was likewise inhibited by PGE1. Both parathyroid hormone and dibutyryl cyclic AMP increased 32P incorporation into renal cortical phospholipids. PGE1 diminished the effect of parathyroid hormone but not dibutyryl cyclic AMP to influence that parameter. PGE1 likewise modulated the effect of parathyroid hormone but not dibutyryl cyclic AMP to decrease fractional phosphate reabsorption by the renal tubule. It is suggested that PGE1 inhibits the effect of parathyroid hormone by decreasing its effect on adenyl cyclase. Such interaction may be important in modulating the intracellular action of parathyroid hormone on kidney cortex.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2352
page 2352
icon of scanned page 2353
page 2353
icon of scanned page 2354
page 2354
icon of scanned page 2355
page 2355
icon of scanned page 2356
page 2356
icon of scanned page 2357
page 2357
icon of scanned page 2358
page 2358
Version history
  • Version 1 (September 1, 1972): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts